ÂÜÀòÂÒÂ×

Bill Farley has over 35 years experience in the Business Development, Sales and leading efforts in drug discovery, development and partnering. Prior to joining the board of directors of XORTX, Mr. Farley held a senior leadership position at Sorrento Therapeutics. Bill, began his career at Johnson and Johnson and has also held senior management positions at Pfizer and HitGen Ltd. and Vice President, WuXi Apptec, Inc. creating, building and leading global business development teams, and Vice President, Business Development at ChemDiv where he led numerous efforts to create new therapeutic companies in CNS, Oncology and Anti infectives. Mr. Farley serves on the board of directors of SOMA and as a consultant to various executive management teams as well as advising several board of directors on commercialization of assets. Mr. Farley has spoken at numerous conferences and is published in variety of journals. He received his Bachelor of Science degree in Chemistry from State University of New York, Oswego and graduate courses at Rutgers and University of California, Irvine.